H.R.8624: Protecting Access to Innovation During COVID–19 Act

About This Bill

  • This bill was introduced in the 116th Congress
  • This bill is primarily about health
  • Introduced Oct. 16, 2020
  • Latest Major Action Oct. 16, 2020

Bill Version

Bill Summary

Protecting Access to Innovation During COVID-19 Act This bill allows the Centers for Medicare & Medicaid Services (CMS) to extend the duration of pass-through status (i.e., additional payment) for certain drugs and devices under the Medicare prospective payment system for hospital outpatient department services. Specifically, the CMS may extend the pass-through status of drugs and devices that received such status during the public health...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There is one statement associated with H.R.8624.

Bill Actions

Date Description
Oct. 16, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct. 16, 2020

Introduced in the House by Brad Wenstrup (R-Ohio)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page